Related Experiment Videos
The drug budget silo mentality in Europe: an overview
1Health Economics & Strategic Pricing, Roche Pharmaceuticals, Basel, Switzerland; Office of Health Economics, London, UK. lou.garrison@roche.com
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pricing combination products: not how but who?
The European journal of health economics : HEPAC : health economics in prevention and care·2025
Proposal for a General Outcome-Based Value Attribution Framework for Combination Therapies.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2024
Implementing an EU pull incentive for antimicrobial innovation and access: blueprint for action.
The Lancet. Microbe·2024
It Takes 2 to Tango. Setting Out the Conditions in Which Performance-Based Risk-Sharing Arrangements Work for Both Parties.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2024
A theory on ICER pricing and optimal levels of cost-effectiveness thresholds: a bargaining approach.
Frontiers in health services·2023
An Application of Iterative Health Economic Evaluation: An Update on the Early Cost Effectiveness of Whole-Genome Sequencing in Advanced Non-small-Cell Lung Cancer.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Does conventional cost-effectiveness analysis disadvantage treatments for severe disease? Evidence from U.S. value assessments.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Incorporating Equity Considerations Related to Financial Protection Through Extended Cost-Effectiveness Analysis: A Systematic Review.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
How Long Should We Wait? The Impact of Immature Data on Colorectal Cancer Decision Modeling.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
What Age is Appropriate for Self-Reporting EQ-5D-Y-3L? Chinese Insights from a Sample of Children Aged 6-11 years.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
How National Volume-Based Procurement Reshapes Drug Prices and Public Spending in China.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Hierarchical Decision-Making Theory: A Cognitive-Affective Framework for Explaining Decision Quality.
Psychology research and behavior management·2026
Self-Determination Theory in the Social Acceptance of Sustainable Energies and Technologies: A Comprehensive Review.
Behavioral sciences (Basel, Switzerland)·2026
Looking at Economics Through the Eyes of Thermodynamics: A New Approach to the Second Law of Economics, and Its Main Revelations.
Entropy (Basel, Switzerland)·2026
How environmental cues shape human face value perceptions-an exploration based on grounded theory.
Frontiers in psychology·2026
China's Low-Carbon Energy Transition Over the Past Two Decades: Experiences and Implications.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
The Bioconservative Stance within Bioethics.
The New bioethics : a multidisciplinary journal of biotechnology and the body·2026